molecules-logo

Journal Browser

Journal Browser

Medicinal Chemistry of Receptor Agonists and Antagonists

A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".

Deadline for manuscript submissions: closed (31 May 2024) | Viewed by 330

Special Issue Editor


E-Mail Website
Guest Editor
Center for Targeted Protein Degradation and Drug Discovery, Ocean University of China, Qingdao 266003, China
Interests: drug discovery; PROTACs; prostate cancer; marine natural active substances
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

A wide range of receptor types, including GPCRs, nuclear receptors, cytokine receptors, hormone receptors, and pattern recognition receptors (PRRs), can serve as drug targets, depending on the specific therapeutic goal and the physiological processes involved. Receptor agonists are substances that activate or stimulate a specific receptor. Receptor antagonists, on the other hand, are substances that block or inhibit the activity of a specific receptor. Therefore, both receptor agonists and antagonists have the potential to be valuable in various clinical contexts, making them highly sought after worldwide. In general, receptor agonists and antagonists typically share an overlapping binding region. Therefore, it is of paramount importance to elucidate the principles behind ligand-induced agonism and antagonism through rational medicinal chemistry approaches, subsequently enabling the transformation of ligands between agonistic and antagonistic effects via structural modifications. This Special Issue aims to provide a forum for the dissemination of the latest advancements in the medicinal chemistry and pharmacology of receptor agonists and antagonists.

Dr. Chong Qin
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • receptor agonists
  • receptor antagonists
  • GPCR
  • nuclear receptors
  • hormone receptors
  • cytokine receptors

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop